CERo Therapeutics Received A Letter From Nasdaq Notifying The Company That It Had Not Regained Compliance With The MVLS Requirement Within The Cure Period; Nasdaq Has Determined To Delist The Company's Securities From Nasdaq On November 8, 2024; On...
Cellectar Biosciences Received A Letter From Nasdaq Informing The Company That It Had Regained Compliance With Nasdaq Listing Rule 5250(c)(1)
Sage Therapeutics Announces Resignation Of Kimi Iguchi From Her Position As CFO And Treasurer Of The Co And From Any And All Other Positions She Holds As An Officer Or Employee Of The Company Or An Officer, Employee Or Director Of Any Of Its Subsidiaries
12 Health Care Stocks Moving In Friday's After-Market Session
Curis Analyst Ratings
Weekly Buzz: Magnificent Mix of Market Reactions